Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FBF14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,311
Award facts
- Contract value 100% obligated
- $62,310.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $62,311 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dupixent 300 mg/2 mL pens. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $1 billion through December 2026. The award was competitively awarded with no set-aside designation, and the product will be delivered from the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive SPE2DX IDC vehicle enables it to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support Defense Health Agency and other government healthcare systems worldwide. This specific delivery order for Dupixent, a specialty pharmaceutical used in treating atopic dermatitis and other allergic conditions, exemplifies the company's role as a key provider of brand-name and specialized medications within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FBF14?
SPE2DB25FBF14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FBF14 worth?
The government has obligated $62,311 on SPE2DB25FBF14.
Is contract SPE2DB25FBF14 an order under another contract?
Yes. SPE2DB25FBF14 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBF14 competed?
The extent of competition for SPE2DB25FBF14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award